4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone

CAS : 134678-17-4

Ref. AN-AG003R7D

Informations sur le produit

• Nom: 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
• Synonymes: 2',3' Dideoxy 3' thiacytidine, 2',3'-Dideoxy-3'-thiacytidine, Epivir, Lamivudine, Lamivudine, (2S-cis)-Isomer, lamivudine, Epivir, Zeffix, Heptovir, Hepitec, Heptodin, Heptivir, (-)-2'-Deoxy-3'-thiacytidine, 3'-Thia-2',3'-dideoxycytidine, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, 2',3'-Dideoxy-3'-thiacytidine, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one, (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine, (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine, Lamivir, Zefix, 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-, (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine, 2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (-)-SddC, Lamivudina, Lamivudinum, Lamivudin, (+/-)-SddC, 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, Lamivudine(Epivir), Lamivudine, 98%, (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one, (2R,5S)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine, .beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To, (+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine, Lamivudine, 1.0 mg/mL in methanol, certified reference material, Lamivudine, Pharmaceutical Secondary Standard; Certified Reference Material, (+/-)-(cis)-4-Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one, 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis), 3-[(5S,2R)-2-(hydroxymethyl)(1,3-oxathiolan-5-yl)]-6-amino-3-hydropyrimidin-2- one, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-[1,3]-oxathiolan-5-yl]-(1H)-pyrimidin-2-one, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-Oxathiolan-5-yl]-(1H)-pyrimidin-2-one, cis(+/-)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone, Combivir, Trizivir, Epzicom, Kuvan, Lamivudine ViiV, Mixture Name, 2'-deoxy-3'-thiacytidine, Lamivudine, (2S-cis)-Isomer, 2',3' Dideoxy 3' thiacytidine, Efavirenz/lamivudine/tenofovir fumarate, 1 3-Oxathiolane 2(1H)-pyrimidinone deriv., 2-Hydroxymethyl-5-(cytosin-1-yl)-1 3-oxathiolane, cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1 3-oxathiolane, Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To, (+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine, (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cystosine, 4-Amino-1-(cis-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, 2(1h)-pirimidinona, 4-amino-1-[(2r,5s)-2-(hidroximetil)-1,3-oxatiolan-5-il]-, 2(1H)-Pyrimidinone 4-amino-1-[2-(hydroxymethyl)-1 3-oxathiolan-5-yl]-(2R-cis)-, (-) 2'-Deoxy-3'-thiacytidine, (-)-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cystosine, (-)-2¢ -Deoxy-3¢ -Thiacytidine, (-)-Bch-189, (-)Ngpb-21, (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone, (2R-cis)-4-amino-1-, 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv., 2(1H)-Pyrimidinone,4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-, 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane, 3'-Thia-2',3'-Dideoxcytidine, 3TC, 3¢ -Thia-2¢ ,3¢ -Dideoxycytidine, 4-amino-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one, <span class="text-smallcaps">L</span>-SddC, Epivir HBV, Gr 109714X, Gr109714X, Hiviral, Lamidine, Virolam, cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane, β-<span class="text-smallcaps">L</span>-2′,3′-Dideoxy-3′-thiacytidine, β-<span class="text-smallcaps">L</span>-3′-Thia-2′,3′-dideoxycytidine
• CAS: 134678-17-4
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 229.2562
• Formule: C₈H₁₁N₃O₃S
• Degré de pureté: 98%
• Couleur/Forme: Solid
• InChI: InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1
• Code InChI: JTEGQNOMFQHVDC-NKWVEPMBSA-N